Helix Acquisition Corp. II Class A Ordinary Shares HLXB | $3.12M | 1.3 | 300,000 | New | +$3.12M | 1.01 | |
| Savara Inc. SVRA | $7.97M | 1.16 | 1.6M | +113.33% | +$4.23M | 2.59 | |
| Replimune Group, Inc. REPL | $5.31M | 1.06 | 650,000 | +62.5% | +$2.04M | 1.73 | |
| Tenaya Therapeutics, Inc. TNYA | $4.05M | 0.99 | 775,000 | New | +$4.05M | 1.32 | |
| Viridian Therapeutics, Inc. VRDN | $10.94M | 0.98 | 625,000 | +108.33% | +$5.69M | 3.56 | |
Perspective Therapeutics, Inc. CATX | $7.14M | 0.94 | 6M | +275% | +$5.24M | 2.32 | |
| Phathom Pharmaceuticals, Inc. PHAT | $5.15M | 0.83 | 485,000 | +25.89% | +$1.06M | 1.67 | |
| Tarsus Pharmaceuticals, Inc. TARS | $10.9M | 0.79 | 300,000 | 0% | +$0 | 3.54 | |
| Aerovate Therapeutics, Inc. AVTE | $6.65M | 0.78 | 225,000 | +7.14% | +$443,550.00 | 2.16 | |
| Cabaletta Bio, Inc. CABA | $6.4M | 0.78 | 375,000 | +150% | +$3.84M | 2.08 | |
| Aquestive Therapeutics, Inc. AQST | $2.99M | 0.77 | 702,941 | New | +$2.99M | 0.97 | |
| Soleno Therapeutics, Inc. SLNO | $8.56M | 0.58 | 200,000 | +77.96% | +$3.75M | 2.78 | |
| TG Therapeutics, Inc. TGTX | $12.55M | 0.53 | 825,000 | +230% | +$8.75M | 4.08 | |
Corbus Pharmaceuticals Holdings, Inc. CRBP | $2.23M | 0.53 | 56,941 | New | +$2.23M | 0.73 | |
| Marinus Pharmaceuticals, Inc. MRNS | $2.58M | 0.52 | 285,000 | +111.11% | +$1.36M | 0.84 | |
| Taysha Gene Therapies, Inc. TSHA | $2.73M | 0.51 | 950,000 | -54.76% | -$3.3M | 0.89 | |
| KalVista Pharmaceuticals, Inc. KALV | $2.37M | 0.47 | 200,000 | +53.8% | +$829,773.04 | 0.77 | |
Cogent Biosciences, Inc. COGT | $3.02M | 0.47 | 450,000 | +130.77% | +$1.71M | 0.98 | |
MoonLake Immunotherapeutics MLTX | $15.07M | 0.47 | 300,000 | +275% | +$11.05M | 4.9 | |
| Axsome Therapeutics, Inc. AXSM | $16.76M | 0.44 | 210,000 | +27.27% | +$3.59M | 5.45 | |
| Revance Therapeutics, Inc. RVNC | $2.21M | 0.43 | 450,000 | +20% | +$369,000.00 | 0.72 | |
| Olema Pharmaceuticals, Inc. OLMA | $2.26M | 0.36 | 200,000 | New | +$2.26M | 0.74 | |
| Altimmune, Inc. ALT | $2.54M | 0.35 | 250,000 | New | +$2.54M | 0.83 | |
Biohaven Pharmaceutical Holding Company Ltd. BHVN | $15.59M | 0.32 | 285,000 | +3.64% | +$546,900.00 | 5.07 | |
| Crinetics Pharmaceuticals, Inc. CRNX | $9.36M | 0.25 | 200,000 | +207.69% | +$6.32M | 3.04 | |
Spyre Therapeutics, Inc. SYRE | $3.79M | 0.25 | 100,000 | New | +$3.79M | 1.23 | |
| REGENXBIO Inc. RGNX | $2.53M | 0.24 | 120,000 | New | +$2.53M | 0.82 | |
| Rhythm Pharmaceuticals, Inc. RYTM | $5.42M | 0.21 | 125,000 | New | +$5.42M | 1.76 | |
Deciphera Pharmaceuticals, Inc. DCPH | $2.78M | 0.2 | 176,513 | -21.55% | -$762,700.38 | 0.9 | |
| Syndax Pharmaceuticals, Inc. SNDX | $3.57M | 0.18 | 150,000 | New | +$3.57M | 1.16 | |
| EyePoint Pharmaceuticals, Inc. EYPT | $1.86M | 0.17 | 90,000 | -45.45% | -$1.55M | 0.61 | |
| Roivant Sciences Ltd. ROIV | $13.7M | 0.16 | 1.3M | +116.67% | +$7.38M | 4.45 | |
| Structure Therapeutics Inc. GPCR | $3.21M | 0.16 | 75,000 | -50% | -$3.21M | 1.05 | |
| ACADIA Pharmaceuticals Inc. ACAD | $4.16M | 0.14 | 225,000 | +350% | +$3.24M | 1.35 | |
| Geron Corporation GERN | $2.64M | 0.14 | 800,000 | New | +$2.64M | 0.86 | |
| Sarepta Therapeutics, Inc. SRPT | $16.18M | 0.13 | 125,000 | +25% | +$3.24M | 5.26 | |
| Protagonist Therapeutics, Inc. PTGX | $2.17M | 0.13 | 75,000 | -40% | -$1.45M | 0.71 | |
| Blueprint Medicines Corporation BPMC | $6.9M | 0.12 | 72,761 | New | +$6.9M | 2.24 | |
CG Oncology, Inc. Common stock CGON | $3.29M | 0.11 | 75,000 | New | +$3.29M | 1.07 | |
| Apellis Pharmaceuticals, Inc. APLS | $7.64M | 0.11 | 130,000 | New | +$7.64M | 2.48 | |
| Insmed Incorporated INSM | $4.07M | 0.1 | 150,000 | New | +$4.07M | 1.32 | |
| BridgeBio Pharma, Inc. BBIO | $5.41M | 0.09 | 175,000 | +40% | +$1.55M | 1.76 | |
| Vaxcyte, Inc. PCVX | $6.49M | 0.09 | 95,000 | +35.71% | +$1.71M | 2.11 | |
| Immunovant, Inc. IMVT | $4.04M | 0.09 | 125,000 | New | +$4.04M | 1.31 | |
| Viking Therapeutics, Inc. VKTX | $5.99M | 0.07 | 73,002 | New | +$5.99M | 1.95 | |
| Arvinas, Inc. ARVN | $1.65M | 0.06 | 40,000 | -32.49% | -$794,640.00 | 0.54 | |
| Krystal Biotech, Inc. KRYS | $2.49M | 0.05 | 14,000 | -72% | -$6.41M | 0.81 | |
| Alnylam Pharmaceuticals, Inc. ALNY | $8.97M | 0.05 | 60,000 | +118.18% | +$4.86M | 2.92 | |
| Madrigal Pharmaceuticals, Inc. MDGL | $1.74M | 0.03 | 6,500 | -56.67% | -$2.27M | 0.56 | |
Natera, Inc. NTRA | $2.29M | 0.02 | 25,000 | -28.57% | -$914,600.00 | 0.74 |